Session Information
2007 Midyear Clinical Meeting
Pharmacosurveillance of Medication Errors in the Neonatal Intensive Care Unit
Track: Educational Session
Program Code: 244-L05
Date: Tuesday, December 4, 2007
Time: 10:00 a.m. - 11:00 a.m.
Location:
Veronese 2401/2402/2501/2502MEETING PLANNING ASSOCIATE:
Mr. John Santell, MS, RPh, Director, Practitioner Programs and Services, U.S. Pharmacopeia
MODERATOR:
Mr. John Santell, MS, RPh, Director, Practitioner Programs and Services, U.S. Pharmacopeia
PRESENTERS:
Mr. John Santell, MS, RPh, Director, Practitioner Programs and Services, U.S. Pharmacopeia
Dr. John Chuo, MD, MS, Director of Neonatal Intensive Care Unit, University of Medicine and Dentistry of New Jersey
Dr. Mary Binghay, PharmD, Pediatric Clinical Specialist/QI Coordinator, Shady Grove Adventist Hospital
LEARNING OBJECTIVES
- Describe the essential components of a neonatal pharmacosurveillance program.
- Describe the research conducted by the Center for Patient Safety in Neonatal Intensive Care aimed at finding ways to effectively prevent errors that occur in Neonatal Intensive Care Unit (NICU).
- Outline pharmacy-specific risk-reduction strategies to improve medication safety in NICU.
AAudio Synchronized to PowerPoint with MP3 Download
(Code: 244-L05)
This session is a part of: